Home/Stocks/Utilities

Centrica PLC

CNA.L·Utilities·Market Cap £9.0b
Rank #6 of 100
Data from Excel Model · 100 Stocks Analysed
£1.97
+14.86% YTD
Target: £2.21(+12.3%)
52W: £1.52 - £2.20
Ad Space

Advertise with Strategyland

strategyland.uk

Score Analysis

Centrica PLC is ranked #6 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

38/100
Average Score
Liquidity
Good33/100
Valuation
Good35/100
Profitability
Excellent14/100
Solvency
Good40/100
Asset Efficiency
Excellent7/100
Mkt Trading
Fair56/100
Technical
Weak78/100

1. Valuation

Score: 35/100

Is CNA undervalued compared to its peers and fair value metrics?

2/5
valuation criteria met
FY26e P/E Ratio
15.6xRank 63/100
FY27e P/E Ratio
13.2xRank 55/100
Price-to-Book
2.53xRank 51/100
Price-to-Tangible Book
3.45xRank 40/100
EV/EBITDA
6.3xRank 20/100

Key Valuation Metrics

Current P/E
N/A
Price-to-Earnings
FY26e P/E
15.6x
Forward estimate
FY27e P/E
13.2x
Forward estimate
P/B Ratio
2.53x
Price-to-Book
P/TBV
3.45x
Price-to-Tangible Book
EV/EBITDA
6.3x
Enterprise Value
FY26e EV/EBITDA
5.6x
Forward estimate
FY27e EV/EBITDA
5.6x
Forward estimate

Analyst Consensus Target

Current Price
£1.97
Consensus Target
£2.21
Potential
+12.3%
Target
Bloomberg Median Target: £2.19

2. Profitability

Score: 14/100

How profitable is CNA relative to its peers?

2/6
profitability criteria met
TTM Profit Margin
-0.2%Rank 5/100
Current ROE
-1.9%
Current ROA
N/A
FY26e EPS
0.15Rank 6/100
TTM EPS
0.13
Net Income Growth
N/A
Profit Margin
-0.2%
ROE
-1.9%
FY27e ROE
20.0%
ROA
N/A

Earnings Per Share

3. Financial Health

Score: 40/100

How strong is CNA's balance sheet and financial position?

1/4
solvency criteria met
Debt-to-Equity
80.4%
Interest Coverage
N/A
Debt/EBITDA
Rank 29Rank 29/100
Altman Z-Score
2.40

Key Health Metrics

Quick Ratio
1.41
Healthy
Cash Ratio
1.45
Debt/Equity
80%
FCF Margin
0.0%

Altman Z-Score

2.40
Grey Zone
01.812.995+

4. Asset Efficiency

Score: 7/100

How efficiently does CNA deploy its assets and intellectual capital?

0/2
asset efficiency criteria met
Intangible/Asset
Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations
N/A
R&D/Sales
Research & development spend relative to revenue — balanced R&D investment signals sustainable growth
N/A

Overall Asset Efficiency Rank

Rank within sector peers#7/100
Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.

4. Dividend

CNA pays a dividend yield of 2.85%.

Current Yield
2.85%
FY27e Yield
3.31%
FY26e DPS
0.037
FY27e DPS
N/A

Dividend Per Share Forecast

5. Technical Analysis

Score: 78/100

What do the technical indicators say about CNA?

0/4
technical criteria met
CMP vs 52W High
-10.6%Rank 42/100
CMP vs 52W Low
29.2%Rank 43/100
RSI 14 Day
30.5Rank 97/100
MA(50) > MA(200)
Yes (Bullish)Rank 46/100

RSI (14 Day)

30.5
Bearish
0 (Oversold)50100 (Overbought)

Moving Averages

MA 30-Day£2.06
MA 50-Day£2.06
MA 200-Day£1.82
SignalGolden Cross (Bullish)
MACD-2.99

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

6. Market Trading

Score: 56/100

How liquid and actively traded is CNA?

1/4
market trading criteria met
5D Avg Volume
16.2M
3M Avg Volume
18.1MRank 14/100
Volume Trend
-10.5%
Beta
N/A
Shares Outstanding
4610587961.0m
Free Float
N/A
Enterprise Value
$8020155.1b

Trading Volume

7. Peer Comparison

How does CNA compare to other Utilities stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
CNA#6333514405678
UU.L#1746419896389
SSE.L#29272654641844
NG.L#33427626871160
SVT.L#53176758976842
MTLN.L#654345515410064
Ad Space

Advertise with Strategyland

strategyland.uk

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.